Caricamento...
AB014. S3A-3. Precision medicine on the horizon for cholangiocarcinoma
Cholangiocarcinoma (CCA) is a molecularly heterogenous group of tumors, and tumor genotyping efforts have uncovered multiple actionable targets in both intrahepatic and extrahepatic tumors. IDH1 mutations, FGFR2 fusions, and BRAF V600E mutations are among the most promising targets to date in CCA-sp...
Salvato in:
| Pubblicato in: | Hepatobiliary Surg Nutr |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421165/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|